Fesoterodine EG 4 mg tabl. prol.-rel.

País: Bélgica

Língua: inglês

Origem: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredientes ativos:

Fesoterodine Fumarate 4 mg - Eq. Fesoterodine 3,1 mg

Disponível em:

EG SA-NV

Código ATC:

G04BD11

DCI (Denominação Comum Internacional):

Fesoterodine Fumarate

Dosagem:

4 mg

Forma farmacêutica:

Prolonged-release tablet

Composição:

Fesoterodine Fumarate 4 mg

Via de administração:

Oral use

Área terapêutica:

Fesoterodine

Resumo do produto:

CTI code: 583680-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 583680-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 583680-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 583680-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 583680-07 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 583680-06 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 583680-05 - Pack size: 84 - Commercialisation status: YES - FMD code: 05400581010019 - CNK code: 4426706 - Delivery mode: Medical prescription; 583680-08

Status de autorização:

Commercialised: Yes

Data de autorização:

2021-04-22